Revolutionising the neurodegenerative space – fundraising, development & beyond


Manage episode 277831061 series 2813433
โดย DRGMarketing และถูกค้นพบโดย Player FM และชุมชนของเรา -- ลิขสิทธิ์นี้เป็นของผู้เผยแพร่ ไม่ใช่ Player FM โดยมีการสตรีมเสียงโดยตรงจากเซิร์ฟเวอร์ผู้เผยแพร่ กดปุ่มติดตามเพื่อติดตามการอัพเดทใน Player FM หรือวาง URL ฟีดนี้ไปยังแอพพอดคาสท์อื่น
In this fireside chat brought to you by Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG talks to Sanjay Kakkar, CEO of San Francisco Bay-based start-up Tranquis Therapeutics. The company focuses on neurodegenerative diseases, an area where significant unmet medical need remains and that has presented the life sciences sector with major challenges for many years. Undaunted, Tranquis Therapeutics has successfully raised $30m in series A for their lead compound. In this interview Sanjay shares the milestones involved in both the development of their compelling compounds that are set to revolutionise the space, as well as the areas that attracted and intrigued their supportive investors. Mike and Sanjay also look to the future and touch on upcoming milestones such as clinical trials and possible commercialisation partnerships.

See for privacy and opt-out information.

36 ตอน